K R I - K R I M I L K I N D U S T R Y S . A . General Commercial Registry No.: 113772252000

INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD

1.1.2023 - 30.9.2023

IN ACCORDANCE WITH IFRS (IAS 34)

(TRANSLATION FROM THE GREEK ORIGINAL)

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023

2

(Amounts in €)

CONTENTS

Page

Condensed Statement of comprehensive income

3

Condensed Statement of financial position

4

Condensed Statement of change in shareholders' equity

5

Condensed Cash flow statement

6

General information

7

Significant accounting policies

7

Notes on Interim Financial Statements

11

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023

3

(Amounts in €)

Condensed Statement of Comprehensive Income

Note.

1/1-30/9/2023

1/1-30/9/2022

Sales

C1

176.673.725

137.266.845

Cost of sales

(113.934.672)

(108.793.695)

Gross profit

C1

62.739.053

28.473.150

Distribution expenses

C1

(22.192.822)

(18.627.142)

Administration expenses

(3.090.046)

(2.706.417)

Research and development expenses

(293.323)

(306.584)

Other income

596.624

644.482

Other (loss) / gain net

173.814

111.011

Profit before taxes, financial and investment income

C1

37.933.300

7.588.500

Financial income

216.589

66.189

Financial expenses

(292.903)

(197.107)

Financial cost of leasing

(21.290)

(20.483)

Financial expenses (net)

(97.604)

(151.401)

Profit before taxes

37.835.696

7.437.099

Income tax

C3

(7.643.228)

(1.510.571)

Net profit for the period (A)

30.192.468

5.926.528

Other comprehensive income after tax (B)

0

0

Total comprehensive income after tax (A + B)

30.192.468

5.926.528

Net profit per share from continuous operations

- Basic and diluted (in €)

0,9184

0,1780

The accompanying notes are an integral part of these financial statements.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023

4

(Amounts in €)

Condensed Statement of Financial Position

Note

30/9/2023

31/12/2022

ASSETS

Non-current assets

Tangible assets

C4

77.806.489

73.879.559

Rights of use of assets

593.830

520.111

Investment in properties

10.082

10.082

Intangible assets

189.118

185.147

Other non-current assets

172.032

181.735

78.771.551

74.776.634

Current assets

Inventories

C5

15.227.427

15.299.030

Trade and other receivables

C6

41.557.174

28.690.740

Current income tax receivables

0

2.110.152

Financial instruments

1.993.516

0

Cash and cash equivalents

28.603.870

7.221.288

87.381.987

53.321.210

Total assets

166.153.538

128.097.844

EQUITY AND LIABILITIES

Equity

Share capital

12.564.752

12.564.752

Reserves

35.686.060

24.686.060

Reserves of own shares

(455.051)

(541.306)

Retained earnings

54.825.477

42.192.614

Total equity

102.621.238

78.902.120

Liabilities

Non-current liabilities

Long term borrowings

C7

11.850.000

6.750.000

Long term portion of leasing

378.926

355.857

Accrued pension and retirement obligations

343.294

304.149

Deferred tax liabilities

4.911.783

4.277.489

Government grants

5.235.536

5.524.536

22.719.539

17.212.031

Current liabilities

Short-term borrowings

C7

6.151.600

7.945.948

Short term portion of leasing

243.689

190.058

Trade and other payables

C8

27.650.644

23.847.688

Current income tax liabilities

6.766.828

0

40.812.761

31.983.694

Total liabilities

63.532.300

49.195.725

Total equity and liabilities

166.153.538

128.097.844

The accompanying notes are an integral part of these financial statements.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023

5

(Amounts in €)

Condensed Statement of changes in equity

Share capital

Balance at 31.12.2021

12.564.752

Profit for the period

Total comprehensive income for the period

Reserves increase

(Purchase) of own shares

Distribution of own shares

Transactions with owners in their capacity as owners

Dividends provided for or paid

Balance at 30.09.2022

12.564.752

Balance at 31.12.2022

12.564.752

Profit for the period

Total comprehensive income for the period

Reserves increase

(Purchase) of own shares

Distribution of own shares

Transactions with owners in their capacity as owners

Dividends provided for or paid

General

Special

Other

reserve

reserves

reserves

4.188.251

20.265.377

38.275

125.382

4.188.251

20.390.759

38.275

4.188.251

20.390.759

38.275

11.000.000

Reserves of own shares

(60.899)

(246.048)

191.367

(115.579)

(541.306)

(267.904)

354.160

Actuarial

gains-losses

Retained earnings

Total Equity

reserve

59.467

45.775.742

82.830.964

5.926.528

5.926.528

5.926.528

5.926.528

(125.382)

0

(246.049)

(8.162)

183.204

(6.613.027)

(6.613.027)

59.467

44.955.699

82.081.621

68.778

42.192.614

78.902.120

30.192.468

30.192.468

30.192.468

30.192.468

(11.000.000)

0

(267.904)

53.423

407.583

(6.613.027)

(6.613.027)

Balance at 30.09.2023

12.564.752

4.188.251

31.390.759

38.275

(455.051)

68.778

54.825.477

102.621.238

The accompanying notes are an integral part of these financial statements.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023

6

(Amounts in €)

Condensed Statement of cash flows

Indirect method

1/1-30/9/2023

1/1-30/9/2022

OPERATING ACTIVITIES

Profit before taxes

37.835.696

7.437.099

Adjustments for:

Depreciation

3.898.970

3.898.413

Provisions

829.228

742.644

Foreign exchange differences, net

(6.907)

23.360

Amortization of government grants relating to capital expenses

(289.000)

(302.855)

Other non-cash items

354.160

191.367

Investment income

(153.758)

(119.875)

Interest and related expenses

314.193

217.590

42.782.581

12.087.741

Changes in working capital:

Decrease / (Increase) in inventories

(16.953)

(2.116.340)

Decrease / (Increase) in receivables (trade)

(13.419.344)

(14.657.589)

Decrease / (Increase) in other receivables

527.356

(289.696)

(Decrease) / Increase in payables (except banks)

5.500.200

11.511.955

Less:

Interest and related expenses paid

(293.203)

(203.442)

Taxes paid

0

(820.140)

Cash flow from operating activities (a)

35.080.637

5.512.489

INVESTING ACTIVITIES

Purchase of tangible and intangible assets

(8.114.661)

(5.791.328)

Proceeds from sales of intangibles and property, plant and equipment

500

24.600

Interest received

216.589

66.189

Purchase of financial instruments

(1.993.516)

0

Cash flow from investing activities (b)

(9.891.088)

(5.700.539)

FINANCING ACTIVITIES

Loans

9.800.000

8.000.000

Repayments of loans

(6.500.000)

(4.355.000)

Repayments of financial leases

(228.132)

(204.162)

Purchase of own shares

(267.904)

(246.049)

Restricted deposits

0

2.230.000

Dividends paid to company's shareholders

(6.610.931)

(6.611.073)

Cash flow from financing activities ( c)

(3.806.967)

(1.186.283)

Change in cash and equivalents (a+b+c)

21.382.582

(1.374.333)

Cash and equivalents at beginning of period

7.221.288

10.749.735

Cash and equivalents at end of period

28.603.870

9.375.402

The accompanying notes are an integral part of these financial statements.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023 (Amounts in €)

Α. General information

KRI-KRI MILK INDUSTRY S.A. operates in the dairy indus- try. Its main business activities is the production of ice- cream and yogurt.

The headquarters are located in 3rd km Serres-Drama, 62125, Serres, Greece, its website is www.krikri.gr and its shares are listed on Athens Stock Exchange (Food sector).

These financial statements have been approved by the Board of Directors on 22 November 2023.

The interim condensed financial statements have not been audited.

Β. Significant accounting policies

Β.1 Basis of preparation

These financial statements covering the period from 1.1.2023 to 30.9.2023 have been prepared according to IAS 34. The basis of their preparation is the historical cost and the "principle of going concern", taking into account all macroeconomic and microeconomic factors and their impact on the smooth operation of the Company.

The interim financial statements for the nine-month period have been prepared on the basis of the same accounting principles followed for the preparation and presentation of the financial statements for the year 2022, except for the new standards and interpretations adopted, the implementation of which was compulsory for periods after 1 January 2023.

Any differences that arise between the amounts in these interim financial statements and the corresponding amounts in the selected explanatory notes as well as in sums are due to rounding.

The interim financial statements should be read in conjunction with the audited financial statements for the year ended 31 December 2022, which have been posted on the Company's website and have been prepared in accordance with IFRSs.

The earnings tax in the interim financial statements is calculated using the tax rate applicable to annual profits.

New standards, amendments to standards and in- terpretations:

Certain new standards, amendments to standards and interpretations have been issued that are mandatory for periods beginning on or after 1.1.2023. The Company's evaluation of the effect of these new standards, amendments to standards and interpretations is as follows:

7

New Standards, Interpretations, Revisions and Amendments to existing Standards that are effective and have been adopted by the European Union

The following new Standards, Interpretations and amendments of IFRSs have been issued by the International Accounting Standards Board (IASB), are adopted by the Eu- ropean Union, and their application is mandatory from or after 01/01/2023.

IFRS 17 "Insurance Contracts" (effective for annual periods starting on or after 01/01/2023)

In May 2017, the IASB issued a new Standard, IFRS 17, which replaces an interim Standard, IFRS 4. The aim of the project was to provide a single principle-based standard to account for all types of insurance contracts, including reinsurance contracts that an insurer holds. A single principle-based standard would enhance comparability of financial reporting among entities, jurisdictions and capital markets. IFRS 17 sets out the requirements that an entity should apply in reporting information about insurance contracts it issues and reinsurance contracts it holds. Further- more, in June 2020, the IASB issued amendments, which do not affect the fundamental principles introduced when IFRS 17 has first been issued. The amendments are designed to reduce costs by simplifying some requirements in the Standard, make financial performance easier to ex- plain, as well as ease transition by deferring the effective date of the Standard to 2023 and by providing additional relief to reduce the effort required when applying the Standard for the first time. The above have been adopted by the European Union with effective date of 01/01/2023.

The amendments do not affect the company's Financial Statements.

Amendments to IAS 1 "Presentation of Financial State- ments" (effective for annual periods starting on or after 01/01/2023)

In February 2021, the IASB issued narrow-scope amendments that pertain to accounting policy disclosures. The objective of these amendments is to improve accounting policy disclosures so that they provide more useful information to investors and other primary users of the financial statements. More specifically, companies are required to disclose their material accounting policy information rather than their significant accounting policies. The above have been adopted by the European Union with effective date of 01/01/2023.

The amendments do not affect substantially the com- pany's Financial Statements.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023 (Amounts in €)

Amendments to IAS 8 "Accounting Policies, Changes in Accounting Estimates and Errors: Definition of Accounting Estimates" (effective for annual periods starting on or after 01/01/2023)

In February 2021, the IASB issued narrow-scope amendments that they clarify how companies should distinguish changes in accounting policies from changes in accounting estimates. That distinction is important because changes in accounting estimates are applied prospectively only to future transactions and other future events, but changes in accounting policies are generally also applied retrospectively to past transactions and other past events. The above have been adopted by the European Union with effective date of 01/01/2023.

The amendments do not affect substantially the com- pany's Financial Statements.

Amendments to IAS 12 "Income Taxes: Deferred Tax related to Assets and Liabilities arising from a Single Trans- action" (effective for annual periods starting on or after 01/01/2023)

In May 2021, the IASB issued targeted amendments to IAS 12 to specify how companies should account for deferred tax on transactions such as leases and decommis- sioning obligations - transactions for which companies recognise both an asset and a liability. In specified circum- stances, companies are exempt from recognising deferred tax when they recognise assets or liabilities for the first time. The amendments clarify that the exemption does not apply and that companies are required to recognise deferred tax on such transactions. The above have been adopted by the European Union with effective date of 01/01/2023.

The amendments do not affect substantially the com- pany's Financial Statements.

Amendments to IFRS 17 "Insurance contracts: Initial Application of IFRS 17 and IFRS 9 - Comparative Infor- mation" (effective for annual periods starting on or after 01/01/2023)

In December 2021, the IASB issued a narrow-scope amendment to the transition requirements in IFRS 17 to address an important issue related to temporary accounting mismatches between insurance contract liabilities and financial assets in the comparative information presented when applying IFRS 17 "Insurance Contracts" and IFRS 9 "Financial Instruments" for the first time. The amendment aims to improve the usefulness of comparative information for the users of the financial statements. The above have been adopted by the European Union with effective date of 01/01/2023.

8

The amendments do not affect substantially the com- pany's Financial Statements.

New Standards, Interpretations, Revisions and Amendments to existing Standards that have not been applied yet or have not been adopted by the European Union

The following new Standards, Interpretations and amendments of IFRSs have been issued by the International Accounting Standards Board (IASB), but their application has not started yet or they have not been adopted by the Eu- ropean Union.

Amendments to IAS 12 "Income taxes": International Tax Reform - Pillar Two Model Rules (effective immediately and for annual periods starting on or after 01/01/2023)

In May 2023, the International Accounting Standards Board (IASB) issued amendments to IAS 12 "Income Taxes": International Tax Reform-Pillar Two Model Rules. The amendments introduced a) a temporary exception to the requirements to recognise and disclose information about deferred tax assets and liabilities related to Pillar Two income taxes and b) targeted disclosure requirements for affected entities. Companies may apply the temporary exception immediately, but disclosure requirements are required for annual periods commencing on or after 1 Jan- uary 2023.

The Company will examine the impact of the above on its Financial Statements, though it is not expected to have any.

The above have not been adopted by the European Union.

Amendments to IAS 1 "Classification of Liabilities as Current or Non-current" (effective for annual periods starting on or after 01/01/2024)

In January 2020, the IASB issued amendments to IAS 1 that affect requirements for the presentation of liabilities. Specifically, they clarify one of the criteria for classifying a liability as non-current, the requirement for an entity to have the right to defer settlement of the liability for at least 12 months after the reporting period. The amendments include: (a) specifying that an entity's right to defer settlement must exist at the end of the reporting period; (b) clarifying that classification is unaffected by manage- ment's intentions or expectations about whether the entity will exercise its right to defer settlement; (c) clarifying how lending conditions affect classification; and (d) clarifying requirements for classifying liabilities an entity will or may settle by issuing its own equity instruments. Furthermore, in July 2020, the IASB issued an amendment to defer by one year the effective date of the initially issued amendment to IAS 1, in response to the Covid-19 pandemic.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023 (Amounts in €)

However, in October 2022, the IASB issued an additional amendment that aim to improve the information companies provide about long-term debt with covenants. IAS 1 requires a company to classify debt as non-current only if the company can avoid settling the debt in the 12 months after the reporting date. However, a company's ability to do so is often subject to complying with covenants. The amendments to IAS 1 specify that covenants to be complied with after the reporting date do not affect the classification of debt as current or non-current at the reporting date. Instead, the amendments require a company to disclose information about these covenants in the notes to the financial statements. The amendments are effective for annual reporting periods beginning on or after 1 Janu- ary 2024, with early adoption permitted.

The Company will examine the impact of the above on its Financial Statements, though it is not expected to have any.

The above have not been adopted by the European Union.

Amendments to IFRS 16 "Leases: Lease Liability in a Sale and Leaseback" (effective for annual periods starting on or after 01/01/2024)

In September 2022, the IASB issued narrow-scope amendments to IFRS 16 "Leases" which add to requirements explaining how a company accounts for a sale and leaseback after the date of the transaction. A sale and leaseback is a transaction for which a company sells an asset and leases that same asset back for a period of time from the new owner. IFRS 16 includes requirements on how to account for a sale and leaseback at the date the transaction takes place. However, IFRS 16 had not specified how to measure the transaction when reporting after that date. The issued amendments add to the sale and leaseback requirements in IFRS 16, thereby supporting the consistent application of the Accounting Standard. These amendments will not change the accounting for leases other than those arising in a sale and leaseback transaction.

The Company will examine the impact of the above on its Financial Statements, though it is not expected to have any.

The above have not been adopted by the European Union.

Amendments to IAS 7 "Statement of Cash Flows" and IFRS 7 "Financial Instruments: Disclosures": Supplier Finance Arrangements (effective for annual periods starting on or after 01/01/2024)

In May 2023, the International Accounting Standards Board (IASB) issued Supplier Finance Arrangements, which amended IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures. The IASB issued

9

Supplier Finance Arrangements to require an entity to provide additional disclosures about its supplier finance ar- rangements. The amendments require additional disclosures that complement the existing disclosures in these two standards. They require entities to provide users of financial statements with information that enable them a) to assess how supplier finance arrangements affect an en- tity's liabilities and cash flows and to understand the effect of supplier finance arrangements on an entity's exposure to liquidity risk and how the entity might be affected if the arrangements were no longer available to it. The amendments to IAS 7 and IFRS 7 are effective for accounting periods on or after 1 January 2024.

The Company will examine the impact of the above on its Financial Statements, though it is not expected to have any.

The above have not been adopted by the European Union.

Amendments to IAS 21 "The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability (effective for annual periods starting on or after 01/01/2025)

In August 2023, the International Accounting Standards Board (IASB) issued amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates that require entities to provide more useful information in their financial statements when a currency cannot be exchanged into another currency. The amendments introduce a definition of currency exchangeability and the process by which an entity should assess this exchangeability. In addition, the amendments provide guidance on how an entity should estimate a spot exchange rate in cases where a currency is not exchangeable and require additional disclosures in cases where an entity has estimated a spot exchange rate due to a lack of exchangeability. The amendments to IAS 21 are effective for accounting periods on or after 1 Janu- ary 2025.

The Company will examine the impact of the above on its Financial Statements, though it is not expected to have any.

The above have not been adopted by the European Union.

Β.2 Financial risk management

The interim financial statements do not include disclosure of all risks required in the preparation of the annual financial statements and should be read in conjunction with the annual financial statements of the Company for the year ended 31 December 2022.

KRI-KRI MILK INDUSTRY S.A.

Interim Financial Statements as of 30 September 2023

10

(Amounts in €)

Β.3 Significant accounting estimates and judgments of the management

The preparation of the interim financial statements requires the Company's management to make estimations, judgments and assumptions that affect the application of the accounting principles and the asset/liability income/ex- pense accounting values. The results are maybe different that these estimations.

For the preparation of the interim financial statements the significant judgments and estimates of the Management regarding the application of the Company's accounting principles are the same as those used for the preparation and presentation of the Company's annual financial statements for the year 2022.

Also, the main sources of uncertainty that existed in the preparation of the annual financial statements of 31 De- cember 2022 remained the same for the interim financial statements as at 30 September 2023.

Β.4 Comparative information

Comparative information is disclosed in respect of the previous period for all amounts reported in the financial state- ments, both face of financial statements and notes. Differences may arise between the amounts stated in the financial statements and the amounts stated in the notes, as a result of numbers rounding.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Kri-Kri Milk Industry SA published this content on 23 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 December 2023 13:16:03 UTC.